STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate

A combination of pancreatic cancer drugs from Tango Therapeutics and Revolution Medicines led to a strong response rate in an early-stage trial.
Source
Stat News
Opens original article in a new tab



